ETC-206

Cat. No.: OB0225WX-1630

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: ETC-206 is a selective kinase inhibitor that targets the MNK1 and MNK2 isoforms with IC50 values measured at 64 nM and 86 nM.

Synonym: 1464151-33-4; Tinodasertib; 4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile; AUM001; AUM-001; 4-[6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile; 4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl}benzonitrile; Benzonitrile, 4-(6-(4-(4-morpholinylcarbonyl)phenyl)imidazo(1,2-a)pyridin-3-yl)-; MFCD31692387; 4-{6-[4-(morpholin-4-ylcarbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl}benzonitrile; 4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2- a]pyridin-3-yl}benzonitrile

CAS No.: 1464151-33-4

Compound CID: 71766360

Formula: C₂₅H₂₀N₄O₂

Formula Weight: 408.45

Specification

Targets&IC50: MNK2: 86 nM; MNK1: 64 nM

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: ETC-206 is applied in medicinal chemistry research as a targeted kinase inhibitor to explore its pharmacodynamic profile and its potential for modulating specific intracellular signaling cascades.